Alaunos Therapeutics Inc. (TCRT)
NASDAQ · Healthcare
Alaunos Therapeutics Inc. Net Income 2011–2025
Alaunos Therapeutics Inc. annual/quarterly net income history and growth rate from 2011 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Alaunos Therapeutics Inc. net income for the quarter ending March 31, 2026 was -1.0 M, a 6.24% decrease year-over-year.
- Alaunos Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -4.3 M, a 65.45% decrease year-over-year.
- Alaunos Therapeutics Inc. annual net income for 2025 was -4.2 M, a 10.75% decrease from 2024.
- Alaunos Therapeutics Inc. annual net income for 2024 was -4.7 M, a 0.00% increase from 2023.
- Alaunos Therapeutics Inc. annual net income for 2023 was -4.7 M, a 87.60% decrease from 2022.
- Alaunos Therapeutics Inc. annual net income for 2022 was -37.7 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Alaunos Therapeutics Inc. Net Income — FAQ
Alaunos Therapeutics Inc. (TCRT) net income over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Alaunos Therapeutics Inc.'s net income?
Alaunos Therapeutics Inc. (TCRT) reported net income of -$4M for fiscal 2025.
Where can I see TCRT's net income history?
The chart and table above show Alaunos Therapeutics Inc.'s net income by year and by quarter, including the growth rate.